Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2018

01-04-2018 | Original Article

Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients

Authors: Jieling Elaine Chen, Vivian Weiqun Lou, Hong Jian, Zhen Zhou, Meiqiong Yan, Jingfen Zhu, Guohong Li, Yaping He

Published in: Supportive Care in Cancer | Issue 4/2018

Login to get access

Abstract

Purpose

The purpose of this study is to examine the effect of financial burden, using objective and subjective indicators, on the health-related quality of life (HRQOL) in lung cancer patients.

Method

A total of 227 patients diagnosed with lung cancer (from the inpatient unit of the department of internal medicine-chest oncology, in Shanghai Chest Hospital, China) participated in the study. Financial information was measured by direct medical costs, direct nonmedical costs, healthcare-cost-to-income ratio, and perceived financial difficulty. HRQOL was measured using the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale.

Findings

Catastrophic health spending, defined as a healthcare-cost-to-income ratio of more than 40%, was reported in 72.7% of the participants, whereas 37.0% reported that healthcare costs exceeded annual household income. Financial difficulty was perceived in 83.7% of the participants. Patients whose healthcare costs exceeded their annual household income and who perceived financial difficulty reported a clinically meaningful difference in overall HRQOL (> 6 points on the FACT-L) compared with participants without catastrophic health spending or perceived financial difficulty. Healthcare costs did not show a significant effect on HRQOL.

Conclusion

Healthcare costs exceeding total annual household income and perceived financial difficulty are associated with poorer HRQOL in lung cancer patients. Subjective indicator of financial burden has a stronger effect on quality of life than objective indicators.

Implication

Health-cost-to-income ratio and perceived financial difficulty can be implied as objective and subjective indicators of financial burden to identify the patients who may need additional assistance. Communication on deciding on cost-effective treatments can be facilitated.
Literature
1.
Chen WQ, Zheng RS, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132CrossRefPubMed
2.
van der Linden N, Bongers ML, Coupe VMH et al (2016) Costs of non-small cell lung cancer in the Netherlands. Lung Cancer 91:79–88CrossRefPubMed
3.
Zeng XH, Kamon J, Wang SY et al (2012) The cost of treating advanced non-small cell lung cancer: estimates from the Chinese experience. PLoS One 7(10):e48323CrossRefPubMedPubMedCentral
4.
Polanski J, Jankowska-Polanska B, Rosinczuk J et al (2016) Quality of life of patients with lung cancer. Onco Targets Ther 9:1023–1028PubMedPubMedCentral
5.
Zarogoulidou V, Panagopoulou E, Papakosta D et al (2015) Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department. J Thorac Dis 7:S12–S19PubMedPubMedCentral
6.
Gupta D, Lis CG, Grutsch JF (2007) Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer. Support Care Cancer 15(9):1051–1056CrossRefPubMed
7.
Delgado-Guay M, Ferrer J, Rieber AG et al (2015) Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist 20(9):1092–1098CrossRefPubMedPubMedCentral
8.
Lathan CS, Cronin A, Tucker-Seeley R et al (2016) Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol 34(15):1732–1740CrossRefPubMedPubMedCentral
9.
Zafar SY, McNeil RB, Thomas CM et al (2015) Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. J Oncol Pract 11(2):145–U472CrossRefPubMed
10.
Choi JW, Park EC, Yoo KS et al (2015) The effect of high medical expenses on household income in South Korea: a longitudinal study using propensity score matching. BMC Health Serv Res 15:369CrossRefPubMedPubMedCentral
11.
Kim Y, Yang B (2011) Relationship between catastrophic health expenditures and household incomes and expenditure patterns in South Korea. Health Policy 100(2–3):239–246CrossRefPubMed
12.
Xu K, Evans DB, Kawabata K et al (2003) Household catastrophic health expenditure: a multicountry analysis. Lancet 362(9378):111–117CrossRefPubMed
13.
Sharp L, Carsin AE, Timmons A (2013) Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psycho-Oncology 22(4):745–755CrossRefPubMed
14.
Perrone F, Jommi C, Di Maio M et al (2016) The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann Oncol 27(12):2224–2229CrossRefPubMed
15.
Azzani M, Roslani AC, Su TT (2016) Financial burden of colorectal cancer treatment among patients and their families in a middle-income country. Support Care Cancer 24(10):4423–4432CrossRefPubMed
16.
Kodama Y, Morozumi R, Matsumura T et al (2012) Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey. BMC Cancer 12:152CrossRefPubMedPubMedCentral
17.
Zaidi AA, Ansari TZ, Khan A (2012) The financial burden of cancer: estimates from patients undergoing cancer care in a tertiary care hospital. Int J Equity Health 11(1):60CrossRefPubMedPubMedCentral
18.
Choi Y, Kim JH, Park EC (2015) The effect of subjective and objective social class on health-related quality of life: new paradigm using longitudinal analysis. Health Qual Life Outcomes 13:121CrossRefPubMedPubMedCentral
19.
Singh-Manoux A, Marmot MG, Adler NE (2005) Does subjective social status predict health and change in health status better than objective status? Psychosom Med 67(6):855–861CrossRefPubMed
20.
Honjo K, Kawakami N, Tsuchiya M et al (2014) Association of subjective and objective socioeconomic status with subjective mental health and mental disorders among Japanese men and women. Int J Behav Med 21(3):421–429CrossRefPubMed
21.
Cella DF, Bonomi AE, Lloyd SR et al (1995) Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality-of-life instrument. Lung Cancer 12(3):199–220CrossRefPubMed
22.
Huang HY, Shi JF, Guo LW et al (2016) Expenditure and financial burden for common cancers in China: a hospital-based multicentre cross-sectional study. Lancet 388:S10CrossRef
23.
24.
Sun YL, Gregersen H, Yuan W (2016) Chinese health care system and clinical epidemiology. Clin Epidemiol 9:167–178CrossRef
25.
26.
27.
Cella D, Eton DT, Fairclough DL et al (2002) What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) questionnaire?: results from Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol 55(3):285–295CrossRefPubMed
28.
Fiteni F, Anota A, Westeel V et al (2016) Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review. BMC Cancer 16(1):122CrossRefPubMedPubMedCentral
29.
Singh-Manoux A, Adler NE, Marmot MG (2003) Subjective social status: its determinants and its association with measures of ill-health in the Whitehall II study. Soc Sci Med 56(6):1321–1333CrossRefPubMed
Metadata
Title
Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients
Authors
Jieling Elaine Chen
Vivian Weiqun Lou
Hong Jian
Zhen Zhou
Meiqiong Yan
Jingfen Zhu
Guohong Li
Yaping He
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3949-4

Other articles of this Issue 4/2018

Supportive Care in Cancer 4/2018 Go to the issue

Original Article

A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients

Original Article

Caregiver social support quality when interacting with cancer survivors: advancing the dual-process model of supportive communication

Original Article

The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation

Review Article

Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review

Original Article

Who is a survivor? Perceptions from individuals who experienced pediatric cancer and their primary support persons

Original Article

Fatigue- and health-related quality-of-life in anemic patients with lymphoma or multiple myeloma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits